Close Window
Welcome :o)
If healthcare, consumer and food products were safe, we wouldn't need a healthcare industry ;o)
or the FDA, CDC, ACA, NIH, etc...
Now THAT sure would save a shit-load of money, wouldn't it ;o)

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Hi All,
This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
Please help keep JohnsonAndToxin ad-free, online and me working to expose Johnson & Johnson and their 275+ subsidiaries for the benefit of every man, woman and child on the planet - and that INCLUDES YOU and the ones YOU love.
NOTE: November 18,2017:
The site ended up going down for two days because I was late with last months' hosting fees. I can't come up with enough money again this month for the hosting fees due on November 26. Without financial support, the site and all content will likely go down again.
Thank you,   
Glad to see you :o)
Hi All,
This is INDEPENDENT work that you are certainly NOT going to see in conventional media.
Gifts of support are always very much appreciated...
Thank you,

Notable visitors to the web site include:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
US Centers for Disease Control
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
Feel free to browse list of notable visitors to the web site.
Sponsored in part by...
Risperdal Boys Project Undisclosed to patients, Risperdal causes breast growth in boys.
----- / / -----
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

Risperdal US Black Box DEATH Warning for Elderly Dementia NOT Applied in AU
Q to Alex Gorsky, Chairman/CEO of Johnson and Johnson, would you give your USA banned drug Risperdal to your father, if he had dementia?

Keywords: risperdal, elderly, dementia, US, Australia, black box, warning, death
Date Created: August 28, 2015

Most Recent Content....
Johnson & Johnson Adds Another Two Thousand Lawsuits in Third Quarter 2017 (2017, November 17)
Lawsuits against Johnson & Johnson continue to spiral out of control - breaking over 108,000 in third quarter 2017, with numerous unmentioned products also racking up an untold number of lawsuits not mentioned in 2017 10-Q.
talc, risperdal, asr, xarelto, baby powder, tvt, mesh, lawsuit
History of Johnson & Johnson Janssen Fentanyl
Hmm, looks like Johnson & Johnson is profiting from BOTH sides of opioid addiction crisis ;o)
15 Steps to Solve Healthcare Crisis
How about this for a rough outline of a strategy to dramatically reduce healthcare costs?
ACA the Affordable CORRUPTION Act
The only purpose of the ACA/ObamaCare was to force everyone to pay legal fees and victim settlements and care from harm by Johnson & Johnson.
Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
Johnson & Johnson Facing Over $100 BILLION in Lawsuit Debt
With a flood of lawsuits pouring in from around the world, Johnson & Johnson is facing at least $100 BILLION lawsuit debt.
The Johnson & Johnson Drugged Kids Pension Plan
Teacher and state retirement funds invest in Johnson & Johnson, the DRUGGED KIDS PENSION PLAN
Second Quarter 2017 Lawsuits Against Johnson & Johnson
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
This article was sent to me by a follower and is posted on his LinkedIn profile. I was asked to post on the Johnson and Toxin site and help to get this information to JNJ investors.
If not , why have you not warned my mother, and all the other Australian mothers and fathers, that your blockbuster anti-pyschotic drug Risperdal has an increased mortality risk for elderly dementia patients, based upon a very short trial period of only 10 weeks?
Yet since 2005, Johnson and Johnson has provided your USA mothers and fathers with the ultimate "black box warning" about the Risperdal death risk as follows:
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. RISPERDAL is not approved for use in patients with dementia-related psychosis.
I challenge you to immediately provide the same black box death warning to all the elderly dementia patients in Australia.
Your 2009 award speech at the Healthcare Businesswoman's Association included the following comments:
"My parents and my five siblings were my first and among the best mentors anyone could wish for. They told me the things that really mattered and delivered many “tough love” messages (as they say) the greatest lessons in life are often learned at home."
How would your mother view your actions now if she was alive? What would your siblings and father advise you now on this issue?
In my opinion, your drug is so powerful in restricting blood flow, and for causing numerous other side effects, that my mother was soon in a wheel chair after taking the medication. When the dose was later increased by 50%, she was immediately bed-ridden that afternoon.
Within two weeks after removing her from your deadly “medication”, she not only was able to resume walking on her own, but also actually walked a recorded 26 minutes NON STOP around the nursing home, without any human assistance.
Does it concern you that dementia is now the no 2 cause of death in Australia, according to the latest statistics from Alzheimer’s Australia (AA)?
AA also notes on its Fight Dementia website, www.fightdementia.org.au:
"about half of people in residential aged care facilities and up to 80% of those with dementia are receiving psychotropic medications, although this varies between facilities. There is evidence to suggest that in some cases these medications have been prescribed inappropriately (Hosia-Randell & Pitkälä, 2005; National Prescribing Service, 2013).
Would you publicly release Risperdal's proportion of this dementia psychotropic market to Australian patients and carers?
You recently published on Mothers Day 2015 the following comments in support of mothers around the world:
"Imagine the world you want to see in 2030—what is important to your family, and what are you doing to make that a reality? Moms +SocialGood is a one-day event dedicated to the power of moms and families to create a better future for their communities, and the role of social media and philanthropy to boost health and happiness for moms and babies everywhere.”

The Global Moms Challenge website at www.globalmomschallenge.org notes it is "an initiative of the United Nations Foundation, which connects people ideas and resources to support the UN and its causes, and is made possible by support from Johnson & Johnson, which is committed to showing that small acts of care can grow into a world of difference."
So do you think your peddling of Risperdal to our mums in Australia is going to boost their health and happiness? If you are really serious about your United Nations project, Moms + SocialGood, will you show a small act of care and withdraw Risperdal immediately from prescription in Australia for elderly dementia patients.
Will you provide written communication to all our medical practitioners in Australia who have been routinely ensuring our nursing home patients are full of anti-psychotic drugs?
Or will Moms+Social Good in Australia, supported by my expanding team of concerned professionals in the medico/legal community, need to show you how “the role of social media and philanthropy” could work to boost the health of moms, by highlighting your company’s lack of governance, absence of corporate ethics and breach of our laws.
I note your army background, and question why our Australian troops are expected to support your country’s so-called “war on terror”, yet you happily steer your army of sales representatives in Australia to every increasing targets, in direct conflict with your prominent black box death warnings in the USA.
I am sure I don’t need to remind you of the unprecedented litigation your company received by a majority of the State and Federal regulators in your country.
I also don't need to remind you of your central role relating to the allegations of payment of kick-backs to doctors, and to Omnicare, the largest nursing home pharmacy, to purchase and recommend Risperdal for dementia patients. My understanding from various reports is that you settled these actions for around US$3 billion, and signed a Corporate Integrity Agreement regulating your future conduct.
As the Chairman and CEO of the Board, a practice rarely condoned these days in Australia for ethical reasons, do you consider your requirement to act with integrity only applies to your behaviour in your own country, and not your strong ally in the war on terror?
I know what my heart says about the real war on terror – and it certainly is not in the Middle East.
I will save my views on how you are treating our young autistic children with Risperdal to another post, and perhaps another forum.
Your immediate action is sought to withdraw this drug for dementia patients in Australia - why should one more mother (or father) have to suffer and die at the hands of Risperdal, whilst your company, and you in particular, examine your conscience.
Can’t you find better causes to make money, linked to health and not death?
Where is your respect for humanity and dignity for our elderly citizens?

All contents Copyright © 2012-2017 Emily Patterson / Johnson and Toxin. All rights reserved.
Web Site and Admin Info:
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
Johnson & Johnson: The Global Lawsuit Company

Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
Johnson & Johnson Credo Analysis
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries